153 MeierJJKemmeriesGHolstJJNauckMA
To stay organized, consider using tools like a digital app, a journal, or a spreadsheet to log your data
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
5,6 JM was scheduled for a phone follow-up in 1 week JM was provided with a demonstration of appropriate injection technique and use of the semaglutide injection device
This type of medication behaves similarly to natural GLP-1 hormones in the body by promoting the production of insulin by the pancreas, supporting a sense of satiety while also slowing the movement of food along the digestive tract and by inhibiting the secretion of glucagon as food is digested
5 While injectable medications like Wegovy and Zepbound often achieve 15-20% weight loss 6,7 , the results of this trial are still clinically meaningful as a 10-15% reduction of body weight provides significant metabolic benefits